LAYOFF UPDATE
Molecular Partners proposes cutting up to 55 positions
TRW published: · Source report: 2026-10-29 · Last checked: 2026-10-29
Original news summary and career guidance by Top Resume Writers. Reporting source: Molecular Partners official announcement.
What the source reports
Molecular Partners announced on October 29 that it intends to eliminate up to 55 positions, approximately 44% of its workforce, while prioritizing targeted radiotherapy. Employee consultation under Swiss law has begun, with implementation expected by Q2 2027. These are proposed company-wide reductions, not confirmed completed layoffs or a US-only count; no country breakdown was provided.
Read the source: Molecular Partners official announcement ↗What the reporting means
The company described a proposed reduction of up to 55 roles, and a Swiss-law consultation process had begun. The final count, individual impact and implementation timetable depend on that process. A proposed company-wide percentage should not be relabelled as completed or exclusively US layoffs.
What applicants can do next
Follow official consultation updates and individual employer communication. Research and operations applicants can document non-confidential programme, laboratory, development or collaboration evidence relevant to their next target role.
Your next move
Follow direct employer communications about consultation, individual impact and support. Prepare a targeted resume showing relevant research, development or operational achievements, while excluding confidential scientific and company information.
This summary reflects the linked reporting when checked. Vacancies and plans can change. Consult official listings and employer communications for current details.